TTK通过双重mTORC1/NF-κB激活定义了一个高风险的口腔状细胞癌亚型
Huan Jin1, Tianjie Liu2, Yucheng Guo3
1Key laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, Shaanxi, China; Department of Pediatric Dentistry, College of Stomatology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
International dental journal
|October 15, 2025
概括
我们确定了一种高风险的口腔状细胞癌 (OSCC) 亚型,由TTK驱动,该亚型激活mTORC1和NF-κB通路. 抑制TTK通过增强西斯普拉丁敏感性,显示出治疗侵略性OSCC的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 口腔状细胞癌 (OSCC) 由于瘤异质性而存在重大治疗挑战.
- 识别不同的分子亚型对于开发向疗法至关重要.
研究的目的:
- 为了全面描述OSCC分子亚型.
- 识别这些亚型中的潜在治疗目标和弱点.
主要方法:
- 从709个OSCC病例的单细胞和大量RNA测序数据的综合分析.
- 使用质谱和免疫沉的蛋白质相互作用研究.
- 在体外和体外功能测定,包括异种移植模型和药物敏感性测试.
主要成果:
- 确定了一种新型的OSCC亚型,其特征是并发的mTORC1和NF-κB通路激活,TTK作为中央调节器.
- 这种亚型表现出高基因组不稳定性,增加瘤突变负担和TP53突变.
- TTK直接与TAK1-TAB复合体相互作用,激活NF-κB;TTK抑制降低了OSCC细胞的增殖,入侵,并增强了对西斯的敏感性.
结论:
- TTK是高风险OSCC亚型的关键调解者,具有激活的mTORC1/NF-κB通路和基因组不稳定性.
- TTK抑制提供了一种潜在的治疗策略,改善了侵略性的OSCC中西斯普拉丁的敏感性.
- 对用于OSCC治疗的TTK抑制剂进行进一步的临床评估是有必要的.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
Receptor Tyrosine Kinases
18.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.0K


